Regulation of osteoblast and osteoclast functions by FGF-6

Journal of Cellular Physiology

Volumn 225, Issue 2, 2010, Pages 466-471

  Bosetti, Michela ^a   Leigheb, Massimiliano ^b   Brooks, Roger A ^c   Boccafoschi, Francesca ^a   Cannas, Mario F ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Major University Hospital   (Italy)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; CALCEIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 6; FIBROBLAST GROWTH FACTOR RECEPTOR 4; MITOGEN ACTIVATED PROTEIN KINASE; ACID PHOSPHATASE; FGF6 PROTEIN, HUMAN; FGFR4 PROTEIN, HUMAN; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE;

ACTIN FILAMENT; ARTICLE; BONE MARROW CELL; BONE METABOLISM; CELL FUNCTION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DENTIN; DOSE RESPONSE; ENZYME ACTIVITY; EVALUATION; HUMAN; MINERALIZATION; MULTINUCLEAR CELL; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; STAINING; TISSUE SLICE; BONE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TIME;

ACID PHOSPHATASE; BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 6; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; OSTEOBLASTS; OSTEOCLASTS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 77956528146     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22225     Document Type: Article

References (30)

1. Armand AS, Laziz I, Chanoine C. 2006. FGF6 in myogenesis. Biochim Biophys Acta 1763:773-778.
2. Bosetti M, Vernè E, Ferraris M, Ravaglioli A, Cannas M. 2001. In vitro characterization of zirconia by bioactive glass. Biomaterials 22:987-994.
3. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
4. Bridgeman G, Brookes M. 1996. Blood supply to the human femoral diaphysis in youth and senescence. J Anatomy 188:611-621. (Pubitemid 26232203)
5. Calle Y, Jones GE, Jagger C, Fuller K, Blundell MP, Chow T, Chambers T, Thrasher AJ. 2004. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 103:3552-3561. (Pubitemid 38525693)
6. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD. 1988. Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci 85:5683-5687.
7. Chikazu D, Hakeda Y, Ogata N, Nemoto K, ltabashi A, Takato T, Kumegawa M, Nakamura K, Kawaguchi H. 2000. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem 275:31444-31450.
8. Cool S, Jackson R, Pincus P, Dickinson I, Nurcombe V. 2002. Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures. Int J Dev Biol 46:519-523.
9. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921. (Pubitemid 26106860)
10. Fakhy A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, Nah HD. 2005. Effects of FGF-2/-9 in calvarial bone cell cultures: Differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36:254-266.
11. Fiore F, Planche J, Gibier P, Sebille A, deLapeyriere O, Birnbaum D. 1997. Apparent normal phenotype of FGF6-/- mice. Int J Dev Biol 41:639-642.
12. Frenkel SR, Herskovits MS, Singh IJ. 1992. Fibroblast growth factor: Effects on osteogenesis and chondrogenesis in the chick embryo. Acta Anat 145:265-268. (Pubitemid 23000015)
13. Gilbert SF. 2006. Specific functions of fibroblast growth factor receptors. In: Developmental biology, 8th edition. Sunderland, MA: Sinauer Associates. Chapter 6.
14. Givol D, Yayon A. 1992. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity. FASEB J 6:3362-3369. (Pubitemid 23007101)
15. Goldfarb M. 1996. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7:311-325. (Pubitemid 27198068)
16. Hale LV, Ma YF, Santerre RF. 2000. Semi-quantitative fluorescence analysis of calcein binding as a measurement of in vitro mineralization. Calcif Tissue Int 67:80-84.
17. Halevy O, Cantley LC. 2004. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Exp Cell Res 297:224-234.
18. Hurley MM, Lee SK, Raisz LG, Bernecker P, Lorenzo J. 1998. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22:309-316.
19. Lakkakorpi PT, Vaananen HK. 1996. Cytoskeletal changes in osteoclasts during the resorption cycle. Microsc Res Tech 33:171-181.
20. Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. 2002. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30:71-77. (Pubitemid 34044303)
21. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093. (Pubitemid 30217693)
22. Ornitz D, Xu J, Colvin J, McEwen D, MacArthur C, Coulier F, Gao G, Goldfarb M. 1996. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297. (Pubitemid 26195013)
23. Pizette S, Coulier F, Birnbaum D, deLapeyriere O. 1996. FGF6 modulates the expression of fibroblast growth factor receptors and myogenic genes in muscle cells. Exp Cell Res 224:143-151.
24. Raucci A, Bellosta P, Grassi R, Basilico C, Mansukhani A. 2008. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J Cell Physiol 215:442-451. (Pubitemid 351468956)
25. Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide A, Maroteaux P, Bonaventure J, Narcy F, Sanak M. 1995. Stop codon FGFR3 mutations in Thanatophoric dwarfism type 1. Nature Genet 10:11-22.
26. Shimoaka T, Ogasawara T, Yonamine A, Chikazu D, Kawano H, Nakamura K, ltoh N, Kawaguchi H. 2002. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J Biol Chem 277:7493-7500.
27. Su N, Yang J, Xie Y, Du X, Lu X, Yin Z, Qi H, Zhao L, Feng J, Chen L. 2008. Gain-of-function mutation of FGFR3 results in impaired fracture healing due to inhibition of chondrocyte differentiation. Biochem Biophys Res Commun 376:454-459.
28. Vainikka S, Partanen J, Bellosta P, Coulier F, Birnbaum D, Basilico C, Jaye M, Alitalo K. 1992. Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J 11:4273-4280.
29. Zhao P, Hoffman EP. 2004. Embryonicmyogenesis pathways in muscle regeneration. Dev Dyn 229:380-392.
30. Zuo J, Jiang J, Dolce C, Holliday S. 2004. Effects of basic fibroblast growth factor on osteoclasts and osteoclast-like cells. Biochem Biophys Res Comm 318:162-167. (Pubitemid 38526260)